Literature DB >> 31027925

Evaluation of future cervical cancer risk in Japan, based on birth year.

Asami Yagi1, Yutaka Ueda2, Sayaka Ikeda3, Masayuki Sekine4, Tomio Nakayama5, Etsuko Miyagi6, Takayuki Enomoto4.   

Abstract

In 2013, following the Ministry of Health, Labor and Welfare (MHLW)'s announced suspension of its vaccine recommendation due to media reports of "adverse events", HPV vaccination dropped to almost 0%. Here, we analyzed, by birth year, the cumulative vaccinations for girls up to age 16 (maximum age for public subsidies) and the results of cervical cancer screening in Matsuyama City. The incidence of CIN3 or worse was 0.09% (7/7872) for these unvaccinated generation born between 1991 and 1993, and 0.00% (0/7389) for the vaccination generation born between 1994 and 1996. This study is the first to show the significant reduction in incidence of CIN3+depending on birth year in Japan. We must keep in mind that the unacceptable high risk for cervical cancer has already begun for an entire new generation of unvaccinated girls born in or after 2000. This data encourages a resumption of MHLW's recommendation for HPV vaccination.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Birth year; CIN3; Cervical cancer; HPV vaccine; Japan

Year:  2019        PMID: 31027925     DOI: 10.1016/j.vaccine.2019.04.044

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Educational intervention for women in Japan coming of age for cervical cancer screening who grew up during the suspended HPV-vaccination-program.

Authors:  Ai Miyoshi; Yutaka Ueda; Asami Yagi; Toshihiro Kimura; Eiji Kobayashi; Kosuke Hiramatsu; Satoshi Nakagawa; Tadashi Kimura
Journal:  Hum Vaccin Immunother       Date:  2021-11-02       Impact factor: 3.452

2.  Internet Survey of Awareness and Behavior Related to HPV Vaccination in Japan.

Authors:  Risa Kudo; Masayuki Sekine; Manako Yamaguchi; Megumi Hara; Sharon J B Hanley; Yutaka Ueda; Asami Yagi; Sosuke Adachi; Megumi Kurosawa; Etsuko Miyagi; Takayuki Enomoto
Journal:  Vaccines (Basel)       Date:  2021-01-25

3.  Risk factors for HPV infection and high-grade cervical disease in sexually active Japanese women.

Authors:  Manako Yamaguchi; Masayuki Sekine; Sharon J B Hanley; Risa Kudo; Megumi Hara; Sosuke Adachi; Yutaka Ueda; Etsuko Miyagi; Takayuki Enomoto
Journal:  Sci Rep       Date:  2021-02-03       Impact factor: 4.379

4.  Trends in cervical cancer incidence and mortality of young and middle adults in Japan.

Authors:  Sayo Tanaka; Matthew Palmer; Kota Katanoda
Journal:  Cancer Sci       Date:  2022-03-15       Impact factor: 6.518

5.  The last strategy for re-dissemination of HPV vaccination in Japan while still under the suspension of the governmental recommendation.

Authors:  Yutaka Ueda; Asami Yagi; Hazuki Abe; Satoshi Nakagawa; Ryoko Minekawa; Haruo Kuroki; Ayako Miwa; Tadashi Kimura
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

6.  Long-term effectiveness of HPV vaccination against HPV infection in young Japanese women: Real-world data.

Authors:  Megumi Kurosawa; Masayuki Sekine; Manako Yamaguchi; Risa Kudo; Sharon J B Hanley; Megumi Hara; Sosuke Adachi; Yutaka Ueda; Etsuko Miyagi; Sayaka Ikeda; Asami Yagi; Takayuki Enomoto
Journal:  Cancer Sci       Date:  2022-02-14       Impact factor: 6.716

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.